Cargando…

Significance of anti‐desmocollin autoantibodies in pemphigus

The major autoantigens for pemphigus are desmogleins (Dsgs), cell–cell adhesive structure proteins, one of the desmosomal cadherins. Recent progress in molecular biology has revealed that IgG autoantibodies of classical pemphigus react with Dsg1 or Dsg3. Desmocollins (Dscs) also belong to the cadher...

Descripción completa

Detalles Bibliográficos
Autor principal: Ishii, Norito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107560/
https://www.ncbi.nlm.nih.gov/pubmed/36578135
http://dx.doi.org/10.1111/1346-8138.16660
_version_ 1785026632139931648
author Ishii, Norito
author_facet Ishii, Norito
author_sort Ishii, Norito
collection PubMed
description The major autoantigens for pemphigus are desmogleins (Dsgs), cell–cell adhesive structure proteins, one of the desmosomal cadherins. Recent progress in molecular biology has revealed that IgG autoantibodies of classical pemphigus react with Dsg1 or Dsg3. Desmocollins (Dscs) also belong to the cadherin supergene family that provides structure to the desmosomes and play an important role in cell‐to‐cell adhesion. In addition to the presence of four desmosomal Dsg isoforms, i.e. Dsg1‐4, Dsc1, 2 and 3, all of which are derived from different genes, Dsc1 has been previously identified as the target antigen of IgA autoantibodies in the subcorneal pustular dermatosis (SPD)‐type of intercellular IgA dermatosis. In addition to the IgA anti‐Dsc1 autoantiboides, the presence of IgG anti‐Dsc autoantibodies is described in patients of some autoimmune bullous diseases. In particular, the current pemphigus detecting autoantibodies to Dscs has shown a tendency in atypical variants of pemphigus. Therefore, autoantibodies against Dscs alone may cause detachment of cell–cell adhesion in the epidermis in some pemphigus. However, except for the findings of a few in vitro and in vivo studies, there is currently no clear evidence for the pathogenicity of anti‐Dsc autoantibodies in pemphigus, whereas significance of anti‐Dsg autoantibodies is well established. This article describes the structure and function of the Dscs, and explores the evidence regarding the pathogenic role of anti‐Dsc autoantibodies in pemphigus.
format Online
Article
Text
id pubmed-10107560
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-101075602023-04-18 Significance of anti‐desmocollin autoantibodies in pemphigus Ishii, Norito J Dermatol Reviews The major autoantigens for pemphigus are desmogleins (Dsgs), cell–cell adhesive structure proteins, one of the desmosomal cadherins. Recent progress in molecular biology has revealed that IgG autoantibodies of classical pemphigus react with Dsg1 or Dsg3. Desmocollins (Dscs) also belong to the cadherin supergene family that provides structure to the desmosomes and play an important role in cell‐to‐cell adhesion. In addition to the presence of four desmosomal Dsg isoforms, i.e. Dsg1‐4, Dsc1, 2 and 3, all of which are derived from different genes, Dsc1 has been previously identified as the target antigen of IgA autoantibodies in the subcorneal pustular dermatosis (SPD)‐type of intercellular IgA dermatosis. In addition to the IgA anti‐Dsc1 autoantiboides, the presence of IgG anti‐Dsc autoantibodies is described in patients of some autoimmune bullous diseases. In particular, the current pemphigus detecting autoantibodies to Dscs has shown a tendency in atypical variants of pemphigus. Therefore, autoantibodies against Dscs alone may cause detachment of cell–cell adhesion in the epidermis in some pemphigus. However, except for the findings of a few in vitro and in vivo studies, there is currently no clear evidence for the pathogenicity of anti‐Dsc autoantibodies in pemphigus, whereas significance of anti‐Dsg autoantibodies is well established. This article describes the structure and function of the Dscs, and explores the evidence regarding the pathogenic role of anti‐Dsc autoantibodies in pemphigus. John Wiley and Sons Inc. 2022-12-28 2023-02 /pmc/articles/PMC10107560/ /pubmed/36578135 http://dx.doi.org/10.1111/1346-8138.16660 Text en © 2022 The Author. The Journal of Dermatology published by John Wiley & Sons Australia, Ltd on behalf of Japanese Dermatological Association. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Reviews
Ishii, Norito
Significance of anti‐desmocollin autoantibodies in pemphigus
title Significance of anti‐desmocollin autoantibodies in pemphigus
title_full Significance of anti‐desmocollin autoantibodies in pemphigus
title_fullStr Significance of anti‐desmocollin autoantibodies in pemphigus
title_full_unstemmed Significance of anti‐desmocollin autoantibodies in pemphigus
title_short Significance of anti‐desmocollin autoantibodies in pemphigus
title_sort significance of anti‐desmocollin autoantibodies in pemphigus
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107560/
https://www.ncbi.nlm.nih.gov/pubmed/36578135
http://dx.doi.org/10.1111/1346-8138.16660
work_keys_str_mv AT ishiinorito significanceofantidesmocollinautoantibodiesinpemphigus